163 related articles for article (PubMed ID: 9061508)
1. 17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas.
Bernini GP; Brogi G; Vivaldi MS; Argenio GF; Sgrò M; Moretti A; Salvetti A
J Endocrinol Invest; 1996 Dec; 19(11):745-52. PubMed ID: 9061508
[TBL] [Abstract][Full Text] [Related]
2. Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas.
Patócs A; Tóth M; Barta C; Sasvári-Székely M; Varga I; Szücs N; Jakab C; Gláz E; Rácz K
Eur J Endocrinol; 2002 Sep; 147(3):349-55. PubMed ID: 12213672
[TBL] [Abstract][Full Text] [Related]
3. Twenty-four hour 17-hydroxyprogesterone response to adrenocorticotropine in adrenal incidentalomas: augmented response after adrenalectomy in two patients.
Kamel N; Erdoğan MF; Tonyukuk V; Ilgin SD; Erdoğan G
Endocr J; 2002 Feb; 49(1):35-40. PubMed ID: 12008748
[TBL] [Abstract][Full Text] [Related]
4. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
Seppel T; Schlaghecke R
Clin Endocrinol (Oxf); 1994 Oct; 41(4):445-51. PubMed ID: 7955456
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of 21-hydroxylase deficiency in adrenal incidentalomas - hormonal and mutation screening.
Wagnerova H; Lazúrová I; Habalová V; Dudásová D; Vrzgula A
Exp Clin Endocrinol Diabetes; 2008 May; 116(5):272-5. PubMed ID: 18589890
[TBL] [Abstract][Full Text] [Related]
6. Low basal androstenedione levels plus augmented 17alpha-hydroxyprogesterone and low dehydroepiandrosterone sulfate responses to adrenocorticotropic hormone stimulation in patients with adrenal incidentaloma.
Ozgen AG; Bayraktar F; Yilmaz C
Endocr Pract; 2001; 7(6):448-53. PubMed ID: 11747281
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of 21-hydroxylase and 11 beta-hydroxylase deficiency in adrenal incidentalomas and in subclinical Cushing's syndrome.
Dall'Asta C; Barbetta L; Libé R; Passini E; Ambrosi B
Horm Res; 2002; 57(5-6):192-6. PubMed ID: 12053092
[TBL] [Abstract][Full Text] [Related]
8. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
Pham-Huu-Trung MT; Gourmelen M; Raux-Eurin MC; Girard F
J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
[TBL] [Abstract][Full Text] [Related]
9. Increased 17 alpha-hydroxyprogesterone response to ACTH in silent adrenal adenoma: cause or effect?
Del Monte P; Bernasconi D; Bertolazzi L; Meozzi M; Badaracco B; Torre R; Marugo M
Clin Endocrinol (Oxf); 1995 Mar; 42(3):273-7. PubMed ID: 7758232
[TBL] [Abstract][Full Text] [Related]
10. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
[TBL] [Abstract][Full Text] [Related]
11. Impairment of 11 beta-hydroxylase but not 21-hydroxylase in adrenal 'incidentalomas'.
Reincke M; Peter M; Sippell WG; Allolio B
Eur J Endocrinol; 1997 Feb; 136(2):196-200. PubMed ID: 9116915
[TBL] [Abstract][Full Text] [Related]
12. A contribution to the classification of cases of non-classic 21-hydroxylase-deficient congenital adrenal hyperplasia.
Phocas I; Chryssikopoulos A; Sarandakou A; Rizos D; Trakakis E
Gynecol Endocrinol; 1995 Sep; 9(3):229-38. PubMed ID: 8540293
[TBL] [Abstract][Full Text] [Related]
13. Congenital adrenal hyperplasia is a very rare cause of adrenal incidentalomas in Sweden.
Sahlander F; Bensing S; Falhammar H
Front Endocrinol (Lausanne); 2022; 13():1017303. PubMed ID: 36545328
[TBL] [Abstract][Full Text] [Related]
14. Incidental adrenal nodules: association with exaggerated 17-hydroxyprogesterone response to adrenocorticotropic hormone.
Turton DB; O'Brian JT; Shakir KM
J Endocrinol Invest; 1992 Dec; 15(11):789-96. PubMed ID: 1337905
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma 17-hydroxyprogesterone response to ACTH in patients with nonhyperfunctioning adrenal adenomas is not due to a deficiency in 21-hydroxylase activity.
Tóth M; Rácz K; Gláz E
J Clin Endocrinol Metab; 1998 Oct; 83(10):3756-7. PubMed ID: 9768700
[No Abstract] [Full Text] [Related]
16. The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation.
Grossrubatscher E; Vignati F; Possa M; Lohi P
J Endocrinol Invest; 2001 Dec; 24(11):846-55. PubMed ID: 11817708
[TBL] [Abstract][Full Text] [Related]
17. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
[TBL] [Abstract][Full Text] [Related]
18. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
19. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates.
Barzon L; Scaroni C; Sonino N; Fallo F; Gregianin M; Macrì C; Boscaro M
J Clin Endocrinol Metab; 1998 Jan; 83(1):55-62. PubMed ID: 9435416
[TBL] [Abstract][Full Text] [Related]
20. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
Feuillan P; Pang S; Schürmeyer T; Avgerinos PC; Chrousos GP
J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
